Literature DB >> 23500513

Dynamics of the systemic components of the chicken (Gallus gallus domesticus) immune system following activation by Escherichia coli; implications for the costs of immunity.

V J Iseri1, K C Klasing.   

Abstract

The immune response is thought to be costly and deters from growth and reproduction, but the magnitude and sources of these costs are unknown. Thus, we quantified the changes in mass of leukocytes (CD4(+) and CD8(+) T cells, Bu1(+) IgM(+) and Bu1(+) IgG(+) B cells, monocytes/macrophages, heterophils and thrombocytes) and protective plasma proteins in systemic (non-mucosal) components of adult chickens injected intravenously with dead Escherichia coli. During the first day after E. coli injection most types of blood leukocytes decreased and α-1-acid glycoprotein increased. Specific IgM, specific IgY, total IgM, Bu1(+) lymphocytes in the spleen and bone marrow and thymic CD8(+) lymphocytes increased at 5d post-injection. Quantitatively, the increases in the weight of cells and antibodies due to E. coli were dwarfed by the increase in the weight of the liver and acute phase proteins. Thus the acute phase response was markedly more costly than the subsequent adaptive response. The weight of the cells and proteins of the systemic immune system prior to challenge was 0.14% of body weight. Following E. coli injection, the additional weight of the immune components and the hypertrophy of the liver resulted in a 3.6-fold increase in weight which is equivalent to 18.5% of a large egg.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23500513     DOI: 10.1016/j.dci.2013.02.005

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  9 in total

1.  Estimating glucose requirements of an activated immune system in growing pigs.

Authors:  S K Kvidera; E A Horst; E J Mayorga; M V Sanz-Fernandez; M Abuajamieh; L H Baumgard
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

2.  Investment in constitutive immune function by North American elk experimentally maintained at two different population densities.

Authors:  Cynthia J Downs; Kelley M Stewart; Brian L Dick
Journal:  PLoS One       Date:  2015-05-20       Impact factor: 3.240

3.  Gut-Associated Lymphoid Tissue: A Key Tissue Inside the Mucosal Immune System of Hens Immunized with Escherichia coli F4.

Authors:  Maria F Peralta; Alejandra Magnoli; Fabrisio Alustiza; Armando Nilson; Raúl Miazzo; Adriana Vivas
Journal:  Front Immunol       Date:  2017-05-22       Impact factor: 7.561

4.  High costs of infection: Alphavirus infection reduces digestive function and bone and feather growth in nestling house sparrows (Passer domesticus).

Authors:  Carol A Fassbinder-Orth; Tess L Killpack; Dylan S Goto; Ellecia L Rainwater; Valerie I Shearn-Bochsler
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

5.  A comparative study of acute-phase protein concentrations in historical and modern broiler breeding lines.

Authors:  E L O'Reilly; R A Bailey; P D Eckersall
Journal:  Poult Sci       Date:  2018-11-01       Impact factor: 3.352

6.  Profile of whole blood gene expression following immune stimulation in a wild passerine.

Authors:  Richard Meitern; Reidar Andreson; Peeter Hõrak
Journal:  BMC Genomics       Date:  2014-06-27       Impact factor: 3.969

7.  Transgenerational effects enhance specific immune response in a wild passerine.

Authors:  Juli Broggi; Ramon C Soriguer; Jordi Figuerola
Journal:  PeerJ       Date:  2016-03-31       Impact factor: 2.984

8.  Protective effect of in ovo treatment with the chicken cathelicidin analog D-CATH-2 against avian pathogenic E. coli.

Authors:  Tryntsje Cuperus; Albert van Dijk; Mieke G R Matthijs; Edwin J A Veldhuizen; Henk P Haagsman
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

9.  Immune responses to improving welfare.

Authors:  L R Berghman
Journal:  Poult Sci       Date:  2016-05-03       Impact factor: 3.352

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.